Strata Critical Medical Statistics
Want to see SRTA full AI Analyst Report?
Strata Critical Medical (SRTA) Stock Statistics & Valuation Metrics
Total Valuation
Strata Critical Medical has a market cap or net worth of $537.71M. The enterprise value is $412.80M.
- Market Cap
- $537.71M
- Enterprise Value
- $412.80M
Share Statistics
Strata Critical Medical has 89,319,855 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 89,319,855
- Owned by Insiders
- 13.98%
- Owned by Institutions
- 30.30%
Financial Efficiency
Strata Critical Medical’s return on equity (ROE) is 0.15 and return on invested capital (ROIC) is -7.30%.
- Return on Equity (ROE)
- 0.15
- Return on Assets (ROA)
- 0.13
- Return on Invested Capital (ROIC)
- -7.30%
- Return on Capital Employed (ROCE)
- -0.07
- Revenue Per Employee
- 602.88K
- Profits Per Employee
- 126.44K
- Employee Count
- 327
- Asset Turnover
- 0.61
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Strata Critical Medical is -20.71. Strata Critical Medical’s PEG ratio is 0.13.
- PE Ratio
- -20.71
- PS Ratio
- 1.92
- PB Ratio
- 1.92
- Price to FCF
- 1680.33
- Price to Operating Cash Flow
- 51.13
- PEG Ratio
- 0.13
Income Statement
In the last 12 months, Strata Critical Medical had revenue of 197.14M and earned 41.35M in profits. Earnings per share was -0.19.
- Revenue
- 197.14M
- Gross Profit
- 41.13M
- Operating Income
- -22.35M
- Pretax Income
- -20.07M
- Net Income
- 41.35M
- EBITDA
- -5.71M
- Earnings Per Share (EPS)
- -0.19
Cash Flow
In the last 12 months, operating cash flow was 10.39M and capital expenditures -10.07M, giving a free cash flow of 320.00K billion.
- Operating Cash Flow
- 10.39M
- Free Cash Flow
- 320.00K
- Free Cash Flow per Share
- 0.00
Dividends & Yields
Strata Critical Medical pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 0.06%
- Earnings Yield
- -4.68%
Stock Price Statistics
- Beta
- 1.92
- 52-Week Price Change
- 24.12%
- 50-Day Moving Average
- 4.97
- 200-Day Moving Average
- 5.07
- Relative Strength Index (RSI)
- 73.01
- Average Volume (3m)
- 956.08K
Important Dates
Strata Critical Medical upcoming earnings date is Mar 16, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 03, 2026
- Next Earnings Date
- Mar 16, 2027
- Ex-Dividend Date
- ―
Financial Position
Strata Critical Medical as a current ratio of 6.38, with Debt / Equity ratio of 1.18%
- Current Ratio
- 6.38
- Quick Ratio
- 6.38
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 4.85
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Strata Critical Medical has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Strata Critical Medical EV to EBITDA ratio is -56.03, with an EV/FCF ratio of 1579.06.
- EV to Sales
- 1.80
- EV to EBITDA
- -56.03
- EV to Free Cash Flow
- 1579.06
- EV to Operating Cash Flow
- 48.61
Balance Sheet
Strata Critical Medical has $41.64M in cash and marketable securities with $3.62M in debt, giving a net cash position of $38.02M billion.
- Cash & Marketable Securities
- $41.64M
- Total Debt
- $3.62M
- Net Cash
- $38.02M
- Net Cash Per Share
- $0.43
- Tangible Book Value Per Share
- $1.31
Margins
Gross margin is 20.59%, with operating margin of -6.63%, and net profit margin of -8.84%.
- Gross Margin
- 20.59%
- Operating Margin
- -6.63%
- Pretax Margin
- -7.52%
- Net Profit Margin
- -8.84%
- EBITDA Margin
- -3.21%
- EBIT Margin
- -8.41%
Analyst Forecast
The average price target for Strata Critical Medical is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 22.73%
- EPS Growth Forecast
- 3.40%
Scores
- Smart Score
- 1
- AI Score
- 60
